What is PharmaCyte Biotech, Inc. (PMCB) stock price today?

PharmaCyte Biotech, Inc. (PMCB) is currently trading at $0.40, up 1.76% today.

What is PMCB P/E ratio?

PharmaCyte Biotech, Inc.'s P/E ratio is -0.17. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PMCB return on equity (ROE)?

PharmaCyte Biotech, Inc.'s return on equity (ROE) is -46.44%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is PharmaCyte Biotech, Inc.'s market cap?

PharmaCyte Biotech, Inc. has a market capitalization of $4.34M.

NASDAQ · Biotechnology

PharmaCyte Biotech, Inc. (PMCB) Stock

$0.40 +1.76% NASDAQ: PMCB Healthcare

Valuation

Metric	Value
Price	$0.40
Market Cap	$4.34M
P/E Ratio	-0.17
P/B Ratio	0.14
P/S Ratio	0.00
EPS (TTM)	$3.19
52-Week High	$1.51
52-Week Low	$0.33
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-46.44%
ROA	-43.98%
ROCE	-19.51%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	7.33

Annual Financials (USD)

Metric	2022	2023	2024	2025	2026
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-4.0M	$-6.0M	$-9.0M	$-4.0M	$-7.0M
Net Profit	$-4.0M	$-4.0M	$0	$31.0M	$-19.0M
EPS	$-0.27	$-0.22	$-1.80	$3.19	$-2.77
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2022	2023	2024	2025	2026
Total Assets	$91.0M	$73.0M	$60.0M	$55.0M	$47.0M
Total Liabilities	$1.0M	$1.0M	$20.0M	$3.0M	$12.0M
Cash	$85.0M	$68.0M	$50.0M	$15.0M	$19.0M
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2022	2023	2024	2025	2026
Operating Cash Flow	$-4.0M	$-4.0M	$-2.0M	$-3.0M	$-5.0M
Investing Cash Flow	$0	$0	$-5.0M	$-7.0M	$2.0M
Financing Cash Flow	$0	$-14.0M	$-44.0M	$-25.0M	$0
Net Cash Flow	$83.0M	$-17.0M	$-18.0M	$-35.0M	$3.0M
Free Cash Flow	$-4.0M	$-4.0M	$-2.0M	$-3.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	2.46
FCF Yield	-91.72%
Quick Ratio	40.30
Interest Coverage	0.00
Return 1Y	-36.20%
Return 3Y	-75.07%
Return 5Y	-94.62%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BCLIBrainstorm Cell Therapeutics Inc.	$0.98	+6.52%	-1.04	$10.81M	0.00%
CYCN	$23.52	+0.00%	-2.42	$15.73M	0.00%
IBOImpact BioMedical, Inc.	$4.33	+5.35%	-4.48	$36.99M	0.00%
KTTAPasithea Therapeutics Corp.	$0.47	+6.03%	-0.19	$15.62M	0.00%
NBYNovaBay Pharmaceuticals, Inc.	$1.47	-24.62%	0.09	$39.14M	2.72%

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is led by CEO Joshua N. Silverman, employs 2 people, headquartered in US, publicly traded since 2013.

PharmaCyte Biotech, Inc. (PMCB) stock trades at $0.40 with a market capitalization of $4.34M. The stock is valued at a price-to-earnings (P/E) ratio of -0.17, price-to-book of 0.14, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.33 and $1.51, and currently trades 73.5% below its 52-week high.

On profitability, PharmaCyte Biotech, Inc. generates a return on equity (ROE) of -46.44%, return on capital employed of -19.51%, an operating margin of 0.00%, a net profit margin of 0.00%.